Category
Osimertinib
CAS Number
1421373-65-0
Molecular Formula
C28H33N7O2
Molecular Weight
499.61 g/mol
Synonym

N-[2-[[2-(Dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-2-propenamide;

Keywords
Amines
Aromatics
Pharmaceutical Standards
Intermediates
Fine Chemicals
Slide_1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Osimertinib is a third-generation EGFR tyrosine kinase inhibitor used primarily for the treatment of non-small cell lung cancer (NSCLC) with specific EGFR mutations, including T790M.It is effective in both first-line therapy and in patients who have developed resistance to earlier EGFR inhibitors.